IL6 and lung carcinoma: Recently, this autocrine mechanism was demonstrated in human lung cancer cells secreting IL-22- [20] and IL-6- [46] induced STAT3 phosphorylation, thus contributing to the pathogenesis of lung adenocarcinoma and formation of pleural effusion.